Maharashtra drug regulator cracks down on 880 illicit medicine suppliers

Maharashtra's drug regulatory authority has launched a sweeping crackdown on unlicensed pharmaceutical operations, inspecting 2,902 drug establishments and taking action against 880 licensees for violations, officials said. The drive reflects growing concerns over the circulation of counterfeit medicines and unregulated cosmetics in the state's healthcare supply chain.

Between June and August, the Food and Drug Administration (FDA) conducted 104 search and seizure operations across the state, resulting in the confiscation of illegal drugs and cosmetics valued at Rs 11.41 crore. The enforcement action also resulted in the registration of 20 first information reports (FIRs), signalling the regulator's determination to prosecute egregious violators.

The intensive inspection and enforcement campaign targets pharmaceutical wholesalers, retailers, and manufacturers operating without proper licensing or in violation of manufacturing standards. Such unauthorized outlets pose significant public health risks, as counterfeit medicines can be ineffective or harmful to consumers. The FDA's coordinated action aims to strengthen the regulatory framework governing drug distribution channels across Maharashtra.

The three-month operation underscores the ongoing challenge of maintaining pharmaceutical safety in a state with complex supply chains and thousands of retail outlets. Regulators have prioritized ground-level enforcement to disrupt the distribution networks of illegal drugs before they reach patients. Industry observers note that such periodic crackdowns remain essential to maintain public confidence in the licensed pharmaceutical sector.